Work

A phase II trial of second-line erlotinib in combination with stereotactic body radiation therapy (SBRT) for patients with metastatic non-small cell lung cancer (NSCLC).

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.8074

Authors: Puneeth Iyengar, Brian D. Kavanagh, Irma Smith, Chul Ahn, David E. Gerber, Johnathan Dowell, Randall S. Hughes, Ramzi Abdulrahman, D. Ross Camidge, Laurie E. Gaspar, Robert Charles Doebele, Paul A. Bunn, Hak Choy, Robert D. Timmerman

Institutions: The University of Texas Southwestern Medical Center, University of Colorado Cancer Center, University of Colorado Denver, Harold C. Simmons Comprehensive Cancer Center

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2909418334

Cites:

Cited by: 3

Related to: 10